| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:2748.)
© 2005 American Heart Association, Inc.
Comments, Opinions, and Reviews |
From the Université Paris-Descartes, Faculté de Médecine, Department of Neurology, Hôpital Sainte-Anne (E.T., J.L.M.); Department of Cardiology, Hôpital Cochin (O.V.); Department of Biostatistics, Hôpital Européen Georges Pompidou, (G.C., S.P.); and Stroke Prevention Research Unit, University Department of Clinical Neurology, Radcliffe Infirmary, Oxford, UK (P.M.R.).
Correspondence to Dr Emmanuel Touzé, Université Paris-Descartes, Faculté de Médecine, Service de Neurologie, Hôpital Sainte-Anne, 1 rue Cabanis, 75674 Paris Cedex 14. E-mail e.touze{at}ch-sainte-anne.fr
Background Whether stroke patients should be investigated for asymptomatic coronary artery disease remains matter of debate. Absolute risks of myocardial infarction (MI) and vascular death after a stroke have not been accurately assessed. We performed a systematic review and a meta-analysis to determine the risk of MI and nonstroke vascular death after transient ischemic attack (TIA) and ischemic stroke. Cohort studies of TIA or ischemic stroke patients were included if they were published between 1980 and March 2005, reported risk of MI and nonstroke vascular death, enrolled >100 patients, and had at least 1 year of follow-up. We included 39 studies in a total of 65 996 patients with mean follow-up of 3.5 years. Two reviewers independently carried out data extraction using a standardized form. Absolute annual risks were estimated through weighted meta-regressions with a random effect. To test the predictions of expected event rates derived from our analysis, we used individual patient data.
Summary of Review The annual risks were 2.1% (CI 95%: 1.9 to 2.4) for nonstroke vascular death, 2.2% (1.7 to 2.7) for total MI, 0.9% (0.7 to 1.2) for nonfatal MI and 1.1% (0.8 to 1.5) for fatal MI. The time course of risk was linear. Estimated risks fitted well with observed risks at the individual level. There was no heterogeneity in the absolute risks according to baseline study characteristics.
Conclusions Patients with TIA or stroke have a relatively high risk of MI and nonstroke vascular death. Additional research is needed to identify the determinants of coronary artery disease in stroke patients.
Key Words: atherosclerosis prognosis risk factors cerebrovascular accident meta-analysis myocardial infarction coronary disease
This article has been cited by other articles:
![]() |
C. A. Jackson, A. Hutchison, M. S. Dennis, J. M. Wardlaw, S. C. Lewis, and C. L.M. Sudlow Differences Between Ischemic Stroke Subtypes in Vascular Outcomes Support a Distinct Lacunar Ischemic Stroke Arteriopathy: A Prospective, Hospital-Based Study Stroke, December 1, 2009; 40(12): 3679 - 3684. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pezzini, M. Grassi, E. Del Zotto, C. Lodigiani, P. Ferrazzi, A. Spalloni, R. Patella, A. Giossi, I. Volonghi, L. Iacoviello, et al. Common genetic markers and prediction of recurrent events after ischemic stroke in young adults Neurology, September 1, 2009; 73(9): 717 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Armario and A. de la Sierra Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents? Therapeutic Advances in Cardiovascular Disease, June 1, 2009; 3(3): 197 - 204. [Abstract] [PDF] |
||||
![]() |
C. S. Roberts, P. B. Gorelick, X. Ye, C. Harley, and G. A. Goldberg Additional Stroke-Related and Non-Stroke-Related Cardiovascular Costs and Hospitalizations in Managed-Care Patients After Ischemic Stroke Stroke, April 1, 2009; 40(4): 1425 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weimar, H.-C. Diener, M. J. Alberts, P. G. Steg, D. L. Bhatt, P. W.F. Wilson, J.-L. Mas, J. Rother, and on behalf of the REACH Registry Investigators The Essen Stroke Risk Score Predicts Recurrent Cardiovascular Events: A Validation Within the REduction of Atherothrombosis for Continued Health (REACH) Registry Stroke, February 1, 2009; 40(2): 350 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Amarenco and P. G. Steg Stroke is a coronary heart disease risk equivalent: implications for future clinical trials in secondary stroke prevention Eur. Heart J., July 1, 2008; 29(13): 1605 - 1607. [Full Text] [PDF] |
||||
![]() |
C Sudlow Preventing further vascular events after a stroke or transient ischaemic attack: an update on medical management Practical Neurology, June 1, 2008; 8(3): 141 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Touze, J. Coste, M. Voicu, J. Kansao, R. Masmoudi, B. Doumenc, P. Durieux, and J.-L. Mas Importance of In-Hospital Initiation of Therapies and Therapeutic Inertia in Secondary Stroke Prevention: IMplementation of Prevention After a Cerebrovascular evenT (IMPACT) Study Stroke, June 1, 2008; 39(6): 1834 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. V. Elkind Prognosis of Transient Neurological Attacks JAMA, April 16, 2008; 299(15): 1771 - 1771. [Full Text] [PDF] |
||||
![]() |
J R Selvarajah, C J Smith, S Hulme, R F Georgiou, A Vail, P J Tyrrell, and on behalf of the NORTHSTAR Collaborators Prognosis in patients with transient ischaemic attack (TIA) and minor stroke attending TIA services in the North West of England: The NORTHSTAR Study J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 38 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Touze, O. Varenne, and J.-L. Mas Overestimation of Coronary Risk in Stroke Patients Stroke, October 1, 2007; 38(10): e98 - e98. [Full Text] [PDF] |
||||
![]() |
M. S. Dhamoon and M. S.V. Elkind Response to Letter by Touze et al Stroke, October 1, 2007; 38(10): e99 - e99. [Full Text] [PDF] |
||||
![]() |
J. Prosser, L. MacGregor, K. R. Lees, H.-C. Diener, W. Hacke, S. Davis, and on behalf of the VISTA Investigators Predictors of Early Cardiac Morbidity and Mortality After Ischemic Stroke Stroke, August 1, 2007; 38(8): 2295 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Hackam and J. D. Spence Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study Stroke, June 1, 2007; 38(6): 1881 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
Ph. G. Steg, D. L. Bhatt, P. W. F. Wilson, R. D'Agostino Sr, E. M. Ohman, J. Rother, C.-S. Liau, A. T. Hirsch, J.-L. Mas, Y. Ikeda, et al. One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis JAMA, March 21, 2007; 297(11): 1197 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Brown, F. Al-Senani, L. D. Lisabeth, M. A. Farnie, L. A. Colletti, K. M. Langa, A. M. Fendrick, N. M. Garcia, M. A. Smith, and L. B. Morgenstern Defining Cause of Death in Stroke Patients: The Brain Attack Surveillance in Corpus Christi Project Am. J. Epidemiol., March 1, 2007; 165(5): 591 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Touze, C. P. Warlow, and P. M. Rothwell Risk of Coronary and Other Nonstroke Vascular Death in Relation to the Presence and Extent of Atherosclerotic Disease at the Carotid Bifurcation Stroke, December 1, 2006; 37(12): 2904 - 2909. [Abstract] [Full Text] [PDF] |
||||
![]() |
Additional articles abstracted in ACP Journal Club Evid. Based Med., August 1, 2006; 11(4): 126 - 126. [Full Text] [PDF] |
||||
![]() |
H. Arima, C. Tzourio, K. Butcher, C. Anderson, M.-G. Bousser, K. R. Lees, J. L. Reid, T. Omae, M. Woodward, S. MacMahon, et al. Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial Stroke, June 1, 2006; 37(6): 1497 - 1502. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |